CD133 Antibody (3F10) - BSA Free

ELISA: CD133 Antibody (3F10) - BSA Free [NBP2-37741]

ELISA: CD133 Antibody (3F10) [NBP2-37741] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);

Immunocytochemistry/ Immunofluorescence: CD133 Antibody (3F10) - BSA Free [NBP2-37741]

Immunocytochemistry/Immunofluorescence: CD133 Antibody (3F10) [NBP2-37741] - Upregulations of TIPRL, LC3 and CD133 in HCCs. Human tissues were stained with the indicated antibodies followed by confocal observation. The representative images were selected from normal and HCCs groups, respectively. DAPI was used for nucleus staining, and scar bars, 20 (inserted) and 100 um. Image collected and cropped by CiteAb from the following publication (//www.nature.com/articles/s41598-019-53191-5) licensed under a CC-BY license.

Immunocytochemistry/ Immunofluorescence: CD133 Antibody (3F10) - BSA Free [NBP2-37741] -

Immunocytochemistry/ Immunofluorescence: CD133 Antibody (3F10) - BSA Free [NBP2-37741] - Significant correlations between levels of TIPRL, LC3 & CD133 in liver cancers. (a–c) The statistically significant associations between levels of TIPRL, LC3 & CD133 in each grade of liver cancers were determined by the Spearman correlation. Each dot indicates a single patient. (d) The representative images were selected from each grade of human liver cancer tissues that were stained with indicated antibodies. DAPI was used for nucleus staining, & scar bar, 100 μm. (e) Quantitative analyses of TIPRL, LC3 & CD133 were conducted according to each grade of liver cancers. (n), the number of samples is indicated. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/31727942), licensed under a CC-BY license. Not internally tested by Novus Biologicals.